We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
826
MetLife
MET
$62.6B
$5.95M 0.01%
126,756
+12,668
+11% +$549K
KPTI icon
827
Karyopharm Therapeutics
KPTI
$159M
$5.9M 0.01%
25,422
BURL icon
828
Burlington
BURL
$23.4B
$5.87M 0.01%
22,433
+44
+0.2% +$9.8K
ONEM
829
DELISTED
1Life Healthcare
ONEM
$5.86M 0.01%
134,308
+25,986
+24% +$888K
PDD icon
830
Pinduoduo
PDD
$122B
$5.86M 0.01%
32,948
+7,060
+27% +$844K
PLUG icon
831
Plug Power
PLUG
$2.75B
$5.86M 0.01%
172,716
-148,950
-46% -$3.37M
BX icon
832
Blackstone
BX
$107B
$5.82M 0.01%
89,831
-52,884
-37% -$3.08M
AMCR icon
833
Amcor
AMCR
$21.5B
$5.82M 0.01%
98,842
-27,434
-22% -$1.56M
XNCR icon
834
Xencor
XNCR
$1.46B
$5.73M 0.01%
131,383
PGR icon
835
Progressive
PGR
$129B
$5.71M 0.01%
58,005
-3,080
-5% -$291K
AIZP
836
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
$5.7M 0.01%
43,883
-267
-0.6% -$33.2K
KC
837
Kingsoft Cloud Holdings
KC
$3.01B
$5.67M 0.01%
130,147
-71,266
-35% -$2.64M
CNI icon
838
Canadian National Railway
CNI
$78.1B
$5.67M 0.01%
51,569
+395
+0.8% +$42.7K
LVS icon
839
Las Vegas Sands
LVS
$31.9B
$5.63M 0.01%
94,455
+28,378
+43% +$1.51M
ALNY icon
840
Alnylam Pharmaceuticals
ALNY
$38.2B
$5.63M 0.01%
43,295
-842
-2% -$112K
RIGL icon
841
Rigel Pharmaceuticals
RIGL
$699M
$5.62M 0.01%
160,479
BGC icon
842
BGC Group
BGC
$5.71B
$5.61M 0.01%
1,403,100
+1,397,800
+26,374% +$4.89M
ZM icon
843
Zoom
ZM
$26.8B
$5.59M 0.01%
16,568
+14,653
+765% +$6.53M
DOOR
844
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$5.56M 0.01%
56,575
-52,272
-48% -$5.08M
XPO icon
845
XPO
XPO
$24.2B
$5.51M 0.01%
133,730
+120,282
+894% +$4.36M
EXC icon
846
Exelon
EXC
$48.7B
$5.5M 0.01%
182,346
-42,803
-19% -$1.26M
CL icon
847
Colgate-Palmolive
CL
$74.9B
$5.42M 0.01%
63,387
+7,722
+14% +$639K
PENN icon
848
PENN Entertainment
PENN
$2.84B
$5.41M 0.01%
62,628
+28,897
+86% +$2.06M
TJX icon
849
TJX Companies
TJX
$177B
$5.36M 0.01%
78,492
-89,023
-53% -$5.41M
SBAC icon
850
SBA Communications
SBAC
$18.8B
$5.34M 0.01%
18,939
-15,519
-45% -$4.56M

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.